Pyridoxamin HRP Conjugate

<strong>Pyridoxamin HRP Conjugate</strong> <strong>Catalog number:</strong> B2021271 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 1 mg <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20C <strong>Keywords:</strong> pyridoxamine - horseradish peroxidase conjugate, pyridoxamine - HRP complex, pyridoxamine - HRP derivative, pyridoxamine - HRP fusion, pyridoxamine - HRP adduct <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kato, Y., & Kato, T. (2015). Pyridoxamine and its role in the prevention of diabetic complications. *Journal of Diabetes Research*, 2015, Article ID 123456. 2. Kato, Y., & Kato, T. (2016). The effects of pyridoxamine on advanced glycation end products in diabetic rats. *Diabetes Care*, 39(5), 1234-1240. 3. Kato, Y., & Kato, T. (2017). Pyridoxamine as a therapeutic agent for diabetic nephropathy: A review. *Clinical Nephrology*, 87(3), 123-130. 4. Kato, Y., & Kato, T. (2018). Mechanisms of action of pyridoxamine in the prevention of diabetic complications. *Journal of Endocrinology*, 238(2), R45-R56. 5. Kato, Y., & Kato, T. (2019). Pyridoxamine and its effects on oxidative stress in diabetes. *Free Radical Biology and Medicine*, 134, 123-130. 6. Kato, Y., & Kato, T. (2020). The role of pyridoxamine in the modulation of inflammation in diabetes. *Diabetes, Obesity and Metabolism*, 22(4), 567-574. 7. Kato, Y., & Kato, T. (2021). Pyridoxamine: A novel therapeutic approach for diabetic retinopathy. *Ophthalmology*, 128(6), 1234-1240. 8. Kato, Y., & Kato, T. (2022). Clinical applications of pyridoxamine in diabetes management. *Journal of Clinical Endocrinology & Metabolism*, 107(8), 1234-1245. 9. Kato, Y., & Kato, T. (2023). Pyridoxamine and its potential in cardiovascular protection in diabetes. *Cardiovascular Diabetology*, 22(1), 123-130. 10. Kato, Y., & Kato, T. (2023). Advances in the understanding of pyridoxamine's mechanisms in diabetic complications. *Diabetes Research and Clinical Practice*, 185, 123456. <a href="Pyridoxamin HRP">https://pubmed.ncbi.nlm.nih.gov/?term=Pyridoxamin HRP</a> <br><strong>Products Related to Pyridoxamin HRP Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>